Model Medicare Advantage and Medicare Prescription Drug Plan Individual Enrollment Request Form (CMS-10718)
Revision of a currently approved collection
No
Regular
Comment filed on proposed rule and continue
04/26/2023
01/25/2023
In accordance with 5 CFR 1320, the information collection is not approved at this time. Prior to publication of the final rule, the agency should provide to OMB a summary of all comments received on the proposed information collection and identify any changes made in response to these comments.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
07/31/2024
36 Months From Approved
07/31/2024
34,026,743
0
34,026,743
8,884,761
0
8,884,761
0
0
0
This 2022 iteration proposes the to update certain reqirements and burden estimates based on our December 27, 2022 (87 FR 79452) proposed rule (CMS-4201-P; RIN 0938-AU96). See section 15 of this Supporting Statement for the net (+/-) changes. See section 12 for the results of the changes. Overall, this iteration increases our burden estimates by 49,559,296 responses (225,906 associated with CMS-4201-P + 49,333,390 non-rule corrections) and 9,795 hours (3,840 associated with CMS-4201-P + 5,955 non-rule corrections).
Included is our Model Individual Enrollment Request Form to Enroll in a Medicare Advantage Plan (Part C) or Medicare Prescription Drug Plan (Part D). We are not proposing any changes to that form.
The MA and Part D enrollment form needed to be in use for the 2023 Medicare Advantage Open Enrollment Period (MA-OEP) which begins January 1, 2023. CMS announced the release of the approved form on July 5, 2022 to allow plans and third-party vendors at least 6 calendar months to implement systems changes.
US Code:
42 USC 1395wâ21
Name of Law: Part C- Medicare + Choice Program: Eligibility, Election and Enrollment
PL:
Pub.L. 105 - 33 4001
Name of Law: Balanced Budget Act of 1997
PL:
Pub.L. 108 - 173 101
Name of Law: Medicare Prescription Drug, Improvement, and Modernization Act of 2003
US Code:
42 USC 1395w-101
Name of Law: Part D Eligible Individuals and Prescription Drug Benefit
This 2022 iteration proposes the to update certain reqirements and burden estimates based on our December 27, 2022 (87 FR 79452) proposed rule (CMS-4201-P; RIN 0938-AU96). See section 15 of this Supporting Statement for the net (+/-) changes. See section 12 for the results of the changes. Overall, this iteration increases our burden estimates by 49,559,296 responses (225,906 associated with CMS-4201-P + 49,333,390 non-rule corrections) and 9,795 hours (3,840 associated with CMS-4201-P + 5,955 non-rule corrections).
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.